Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
PaperCitations, authors & open-access status
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 336 citations, 2023 year and bronze oa status.
336
Citations
2023
Year
bronze
OA Status